1. Introduction
===============

Pyrimidine and its derivatives, which are important *N*-heterocyclic molecules, have received the consideration of researchers due to their significant biological and pharmaceutical properties. Pyrimidine and its derivatives have immense importance as antibiotics, and as crucial parts of many vitamins, and coenzymes. Indeed, some of them are the basic constituents of DNA and RNA, and play an important role in the constitutional properties of nucleic acids. Pyrimidine-derived biomolecules have received much attention from spectroscopists, drug, clinical, and industrial researchers because of their therapeutic importance \[[@B1-molecules-19-17187],[@B2-molecules-19-17187],[@B3-molecules-19-17187],[@B4-molecules-19-17187],[@B5-molecules-19-17187],[@B6-molecules-19-17187],[@B7-molecules-19-17187],[@B8-molecules-19-17187],[@B9-molecules-19-17187]\]. Barbiturates (barbituric acid derivatives) are a class of central nervous system depressants, \[[@B10-molecules-19-17187]\] utilized as sedatives, sleeping agents, hypnotics, anxiolytics, anticonvulsants, and anesthetics \[[@B7-molecules-19-17187]\]. In addition, they have additional pharmacological activities as antioxidant anxiolitics, analeptics, anti-AIDA, immunomodulatory, anticancer agents and in other psychiatric disorders, and possess effects on motor and sensory functions \[[@B11-molecules-19-17187],[@B12-molecules-19-17187],[@B13-molecules-19-17187],[@B14-molecules-19-17187],[@B15-molecules-19-17187]\] For example, phenobarbital, a 5-alkylated barbituric acid, was reported to exhibit sedative and hypnotic properties, and most importantly is an anticonvulsant \[[@B16-molecules-19-17187]\].

In continuation of our research program \[[@B17-molecules-19-17187],[@B18-molecules-19-17187],[@B19-molecules-19-17187],[@B20-molecules-19-17187],[@B21-molecules-19-17187],[@B22-molecules-19-17187],[@B23-molecules-19-17187]\], in the present work, the structures of some pyrimidine derivatives were characterized for the first time by single-crystal crystallography and TGA studies. DFT calculations were undertaken to study the optimized molecular structural parameters, vibrational frequencies, thermodynamic parameters, total dipole moment and HOMO-LUMO energy gap for the synthesized molecules using B3LYP/6-311G(d,p) basis set. The findings of these spectroscopic and theoretical studies are reported herein.

2. Results and Discussion
=========================

2.1. Synthesis of the Pyrimidine Derivatives
--------------------------------------------

Green chemistry is being increasingly exploited as a powerful tool for the generation of privileged medicinal scaffolds and fine chemicals due to its numerous advantages, such as providing high enantio- and regioselectivity and more environmentally friendliness.

Recently, research groups have become involved in using green chemistry as a synthetic tool for the generation of valuable scaffolds to achieve new biological knowledge. The chemistry used in this paper involves an aqueous diethylamine catalyzed Michael addition of 1,3-dimethylbarbituric acid to nitro-olefins at room temperature for less than 1 h \[[@B16-molecules-19-17187]\] ([Scheme 1](#molecules-19-17187-f006){ref-type="scheme"}).

2.2. X-ray Crystal Structures
-----------------------------

The structures of **1a** and **2a**,**b** were confirmed by single crystal X-ray analysis ([Figure 1](#molecules-19-17187-f001){ref-type="fig"}). [Table 1](#molecules-19-17187-t001){ref-type="table"}, [Table 2](#molecules-19-17187-t002){ref-type="table"}, [Table 3](#molecules-19-17187-t003){ref-type="table"}, [Table 4](#molecules-19-17187-t004){ref-type="table"}, [Table 5](#molecules-19-17187-t005){ref-type="table"}, [Table 6](#molecules-19-17187-t006){ref-type="table"} and [Table 7](#molecules-19-17187-t007){ref-type="table"} display the crystal data and main geometrical parameters of the compounds.

X-ray analysis was performed using a Bruker Apex II D8 Venture diffractometer (Bruker AXS GmbH, Karlsruhe, Germany). The data were processed with SAINT and corrected for absorption using SADABS \[[@B24-molecules-19-17187]\]. The structure was solved by direct method using the program SHELXTL \[[@B25-molecules-19-17187]\] and were refined by full-matrix least squares technique on *F*^2^ using anisotropic displacement parameters. The non-hydrogen atoms were refined anisotropically. In these compounds, all the H atoms were calculated geometrically with isotropic displacement parameters set to 1.2 times the equivalent isotropic U values of the parent carbon atoms.

![Synthesis of pyrimidine derivatives **2a** and **2b**.](molecules-19-17187-g006){#molecules-19-17187-f006}

![ORTEP diagrams of the structures of **1a** and **2a**,**b**.](molecules-19-17187-g001){#molecules-19-17187-f001}

The title compound **1a**, C~8~H~5~Cl~2~NO~2~, which crystallizes in the monoclinic space group P 21/c comprises one crystallographically independent molecule in its asymmetric unit, as depicted in [Figure 1](#molecules-19-17187-f001){ref-type="fig"}. In the crystal structure ([Figure 2](#molecules-19-17187-f002){ref-type="fig"}A), there is an intramolecular C7-H7A···O2 hydrogen bond. The crystal is essentially consolidated by Van Der Waals interactions. The crystal data and parameters for structure refinement of the title compound are given in [Table 1](#molecules-19-17187-t001){ref-type="table"}. Selected geometric parameters are given in [Table 2](#molecules-19-17187-t002){ref-type="table"}. H-bonding interactions are listed in [Table 3](#molecules-19-17187-t003){ref-type="table"}.

The title compound **2a**, C~14~H~13~Cl~2~N~3~O~5~·H~2~O, which crystallizes in the trigonal space group R-3 comprises one crystallographically independent molecule with disorder in the phenyl ring and a water molecule in its asymmetric unitas shown in [Figure 1](#molecules-19-17187-f001){ref-type="fig"}. [Figure 2](#molecules-19-17187-f002){ref-type="fig"}B shows the crystal packing for the major and minor components of **2a** respectively with occupancy ratio 0.755:0.245. There are two intermolecular C6-H6A···O2 and C9-H9A···O3 hydrogen bonds ([Table 5](#molecules-19-17187-t005){ref-type="table"}). The crystal structure is further consolidated by Van Der Waals interactions. The crystal data and parameters for structure refinement of the title compound are given in [Table 1](#molecules-19-17187-t001){ref-type="table"}. Selected geometric parameters are given in [Table 4](#molecules-19-17187-t004){ref-type="table"}. H-bonding interactions are listed in [Table 5](#molecules-19-17187-t005){ref-type="table"}.

![Crystal packings of (**A**) **1a**, (**B**) **2a** and (**C**) **2b**.](molecules-19-17187-g002){#molecules-19-17187-f002}

The title compound **2b**, C~14~H~13~Cl~2~N~3~O~5~, which crystallizes in the monoclinic space group Cc comprises one crystallographically independent molecule in its asymmetric as shown in [Figure 1](#molecules-19-17187-f001){ref-type="fig"}. In the crystal structure ([Figure 2](#molecules-19-17187-f002){ref-type="fig"}C), there are two intermolecular C6-H6A···O1 and C13-H13C···O5 hydrogen bonds ([Table 7](#molecules-19-17187-t007){ref-type="table"}). The crystal is further consolidated by Van Der Waals interactions. The crystal data and parameters for structure refinement of the title compound are given in [Table 1](#molecules-19-17187-t001){ref-type="table"}. Selected geometric parameters are given in [Table 6](#molecules-19-17187-t006){ref-type="table"}. H-bonding interactions are listed in [Table 7](#molecules-19-17187-t007){ref-type="table"}.

molecules-19-17187-t001_Table 1

###### 

Crystal and experimental data of compounds **1a**, **2a** and **2b**.

  Parameters                          Compound 1a                                                                                      Compound 2a                                                                               Compound 2b
  ----------------------------------- ------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  Empirical formula                   C~8~H~5~Cl~2~NO~2~                                                                               C~14~H~13~Cl~2~N~3~O~5~·H~2~O                                                             C~14~H~13~Cl~2~N~3~O~5~
  Formula weight                      218.03                                                                                           391.02                                                                                    374.17
  Temperature                         293(2) K                                                                                         293(2) K                                                                                  293(2) K
  Wavelength (Mo *K*α radiation, λ)   0.71073 Å                                                                                        0.71073 Å                                                                                 0.71073 Å
  Crystal system                      monoclinic                                                                                       trigonal                                                                                  Monoclinic
  Space group                         P 21/c                                                                                           R-3                                                                                       Cc
  Unit cell dimensions                a = 3.8395 (1) Å, α = 90.00° b = 19.8653 (7) Å β = 90.6258 (10)° c = 11.9619 (4) Å, γ = 90.00°   a = 18.0177(7) Å, α = 90.00° b = 18.0177(7) Å, β = 90.00° c = 26.6558(9) Å, γ = 120.00°   a = 12.9432 (4) Å, α = 90.00° b = 9.3084 (4) Å, β = 101.3572 (16)° c = 13.4650 (5) Å, γ = 90.00°
  Volume                              912.31 (5)Å^3^                                                                                   7494.1(6) Å^3^                                                                            1590.51 (11) Å^3^
  Z                                   4                                                                                                6                                                                                         4
  Density (calculated)                1.587 Mg/m^3^                                                                                    1.535 Mg/m^3^                                                                             1.563 Mg/m^3^
  Absorption coefficient              0.67 mm^−1^                                                                                      0.424 mm^−1^                                                                              0.439 mm^−1^
  *F*(000)                            440                                                                                              3564                                                                                      768
  Crystal size                        0.58 × 0.35 × 0.27 mm                                                                            0.33 × 0.21 × 0.09 mm                                                                     0.57 × 0.35 × 0.26 mm
  Theta range for data collection     2.7 to 30.5°.                                                                                    2.3 to 30.6°.                                                                             2.7 to 30.6°.
  Index ranges                        −5 ≤ h ≤ 5, −28 ≤ k ≤ 28, −17 ≤ l ≤ 17                                                           −25 ≤h ≤ 25, −25 ≤ k ≤ 25, −38 ≤ l ≤ 38                                                   −18 ≤ h ≤ 18, −13 ≤ k ≤ 13, −19 ≤ l ≤ 19
  Reflections collected/ unique       41303/2404 \[R(int) = 0.042\]                                                                    107278/5130 \[R(int) = 0.059\]                                                            35961/4754 \[R(int) = 0.024\]
  Completeness to theta = 30.57°      99.8%                                                                                            99.6%                                                                                     99.6%
  Absorption correction               multi-scan                                                                                       multi-scan                                                                                multi-scan
  Refinement                          method Full-matrix least-squares on *F*^2^                                                       method Full-matrix least-squares on *F*^2^                                                method Full-matrix least-squares on *F*^2^
  Goodness-of-fit on *F*^2^           1.04                                                                                             1.03                                                                                      1.27
  Largest diff. peak and hole         0.28 and −0.22 e.Å^−3^                                                                           0.72 and −0.26 e.Å^−3^                                                                    0.22 and −0.25 e.Å^−3^

molecules-19-17187-t002_Table 2

###### 

Selected geometric parameters (Å, °) of compound **1a**.

  ---------------- ------------------ ----------------
  **Bond**         **Experimental**   **Calculated**
  Cl1-C1           1.7320 (13)        1.7314
  Cl2-C5           1.7295 (14)        1.7405
  O1-N1            1.222 (2)          1.2370
  O2-N1            1.211 (2)          1.2372
  N1-C8            1.4563 (18)        1.4511
  **Atom Angle**   **Experimental**   **Calculated**
  O1-N1-O2         124.37 (14)        125.1111
  O1-N1-C8         115.73 (14)        115.6492
  O2-N1-C8         119.90 (14)        119.2397
  Cl1-C1-C2        117.62 (11)        124.7209
  Cl1-C1-C6        120.34 (9)         113.6358
  Cl2-C5-C4        118.18 (11)        114.3525
  Cl2-C5-C6        119.58 (10)        123.4094
  N1-C8-C7         120.57 (13)        119.8515
  ---------------- ------------------ ----------------

molecules-19-17187-t003_Table 3

###### 

Hydrogen-bond geometry (Å, °) of compound **1a**.

  *D*-H···*A*   *D*-H    H···*A*   *D*···*A*      *D*-H···*A*
  ------------- -------- --------- -------------- -------------
  C7-H7A···O2   0.9300   2.4000    2.7323  (18)   101.00

molecules-19-17187-t004_Table 4

###### 

Selected geometric parameters (Å, °) of compound **2a**.

  ---------------------- ------------------ ----------------
  **Bond**               **Experimental**   **Calculated**
  Cl1A-C8A               1.738 (4)          1.7277
  Cl1B-C8B               1.721 (14)         NC
  Cl2A-C12A              1.751 (6)          1.7365
  Cl2B-C12B              1.715 (14)         NC
  O1-C1                  1.204 (2)          1.2278
  O2-C2                  1.205 (2)          1.2325
  O3-C3                  1.212 (2)          1.2276
  O4-N3                  1.196 (3)          1.2362
  O5-N3                  1.215 (3)          1.2378
  O1W-O1W ^i^            0.969 (19)         NC
  O1W-O1W ^ii^           0.97 (2)           NC
  N1-C1                  1.378 (2)          1.3855
  N1-C13                 1.473 (3)          1.4513
  N1-C2                  1.382 (2)          1.3724
  N2-C2                  1.387 (3)          1.3925
  N2-C14                 1.463 (3)          1.4515
  N2-C3                  1.370 (2)          1.3881
  N3-C6                  1.500 (2)          1.4962
  **Atom Angle**         **Experimental**   **Calculated**
  O1W ^ii^-O1W-O1W ^i^   60.0 (18)          NC
  C1-N1-C2               124.36 (15)        122.9525
  C2-N1-C13              117.61 (15)        117.6313
  C1-N1-C13              117.39 (15)        117.0595
  C2-N2-C3               124.74 (15)        123.0628
  C3-N2-C14              117.62 (17)        116.9594
  C2-N2-C14              117.50 (16)        117.4505
  O4-N3-C6               121.03 (18)        117.2445
  O4-N3-O5               123.45 (19)        125.7819
  O5-N3-C6               115.53 (16)        116.9697
  O1-C1-N1               121.69 (16)        123.7575
  O1-C1-C4               121.91 (15)        122.9936
  N1-C1-C4               116.24 (15)        113.2488
  O2-C2-N2               120.68 (18)        123.3871
  N1-C2-N2               117.42 (14)        116.2983
  O2-C2-N1               121.9 (2)          121.7454
  O3-C3-C4               121.55 (15)        123.7560
  O3-C3-N2               121.13 (15)        121.7802
  N2-C3-C4               117.24 (14)        112.8565
  N3-C6-C5               112.43 (14)        111.9825
  Cl1A-C8A-C7A           119.7 (3)          124.0885
  Cl1A-C8A-C9A           117.4 (3)          114.4806
  Cl1B-C8B-C9B           116.7 (10)         NC
  Cl1B-C8B-C7B           121.7 (9)          NC
  Cl2A-C12A-C7A          120.8 (3)          122.7008
  Cl2A-C12A-C11A         114.7 (4)          115.2511
  Cl2B-C12B-C7B          122.5 (8)          NC
  Cl2B-C12B-C11B         114.4 (10)         NC
  ---------------------- ------------------ ----------------

Symmetry codes: (i) --*x* + *y* + 1, −*x* + 1, *z*; (ii) --*y* + 1, *x* − *y*, *z*. NC: Not calculated.

molecules-19-17187-t005_Table 5

###### 

Hydrogen-bond geometry (Å, °) of compound **2a**.

  *D*-H···*A*            *D*-H    H···*A*   *D*···*A*    *D*-H···*A*
  ---------------------- -------- --------- ------------ -------------
  O1W-H2W1···O1W ^iii^   0.9100   2.1000    2.859  (6)   140.00
  O1W-H2W1···O1W ^iv^    0.9100   1.8500    2.689  (6)   152.00
  O1W-H2W1···O1W ^v^     0.9100   2.0500    2.689  (7)   125.00
  C5-H5A···O4            0.9800   2.2700    2.741  (3)   108.00
  C6-H6A···O1 ^vi^       0.9700   2.5300    3.337  (3)   141.00
  C6-H6B···Cl2A          0.9700   2.6800    3.125  (4)   109.00
  C6-H6B···O3            0.9700   2.5800    2.979  (2)   105.00
  C13-H13A···O2          0.9600   2.2900    2.716  (3)   106.00
  C13-H13C···O5 ^vii^    0.9600   2.5100    3.425  (3)   159.00
  C14-H14B···O2          0.9600   2.2400    2.690  (4)   108.00

Symmetry codes: (iii) −*x* + 4/3, −*y* + 2/3, −*z* + 2/3; (iv) *y* + 1/3, −*x* + *y* + 2/3, −*z* + 2/3; (v) *x* − *y* + 1/3, *x* − 1/3, −*z* + 2/3; (vi) *y* − 1/3, −*x* + *y* + 1/3, −*z* + 4/3; (vii) −*x* + *y*, −*x*, *z*.

molecules-19-17187-t006_Table 6

###### 

Selected geometric parameters (Å, °) of compound **2b**.

  ---------------- ------------------ ----------------
  **Bond**         **Experimental**   **Calculated**
  Cl1-C12          1.7310 (11)        1.7247
  Cl2-C10          1.7338 (13)        1.7195
  O1-C1            1.2101 (19)        1.2276
  O2-C2            1.219 (2)          1.2325
  O3-C3            1.2148 (16)        1.2278
  O4-N3            1.212 (2)          1.2362
  O5-N3            1.204 (3)          1.2378
  N1-C1            1.376 (2)          1.3881
  N1-C2            1.386 (2)          1.3925
  N1-C13           1.469 (2)          1.4515
  N2-C2            1.3947 (19)        1.4071
  N2-C3            1.3661 (16)        1.3855
  N2-C14           1.471 (2)          1.4513
  N3-C6            1.496 (2)          1.4962
  **Atom Angle**   **Experimental**   **Calculated**
  C1-N1-C2         124.73 (12)        122.7743
  C1-N1-C13        117.37 (15)        117.4505
  C2-N1-C13        117.89 (15)        117.0006
  C2-N2-C3         124.33 (11)        122.9525
  C2-N2-C14        117.89 (12)        117.0593
  C3-N2-C14        117.64 (12)        117.6313
  O4-N3-O5         122.4 (2)          125.7819
  O4-N3-C6         118.79 (15)        116.9697
  O5-N3-C6         118.86 (17)        117.2445
  O1-C1-N1         122.31 (14)        123.3871
  O1-C1-C4         120.81 (13)        123.7560
  N1-C1-C4         116.80 (12)        112.8565
  O2-C2-N1         121.70 (15)        121.7802
  O2-C2-N2         120.54 (14)        121.7454
  N1-C2-N2         117.74 (12)        116.2983
  O3-C3-N2         121.68 (12)        123.7575
  O3-C3-C4         121.06 (11)        122.9936
  N2-C3-C4         117.18 (10)        113.2488
  N3-C6-C5         109.74 (11)        111.9825
  Cl2-C10-C9       118.98 (10)        119.8634
  Cl2-C10-C11      119.27 (9)         119.9545
  Cl1-C12-C7       121.01 (8)         123.6597
  Cl1-C12-C11      116.44 (9)         115.4596
  ---------------- ------------------ ----------------

molecules-19-17187-t007_Table 7

###### 

Hydrogen-bond geometry (Å, °) of compound **2b**.

  *D*-H···*A*        *D*-H    H···*A*   *D*···*A*      *D*-H···*A*
  ------------------ -------- --------- -------------- -------------
  C6-H6A···O2 ^i^    0.9700   2.3900    3.222  (2)     144.00
  C6-H6B···O1        0.9700   2.5500    3.118  (2)     117.00
  C9-H9A···O3 ^ii^   0.9300   2.5100    3.2290  (18)   134.00
  C13-H13B···O2      0.9600   2.3100    2.727  (3)     105.00
  C14-H14C···O2      0.9600   2.2700    2.715  (2)     107.00

Symmetry codes: (i) *x*, −*y* + 1, *z*+1/2; (ii) *x* − 1/2, *y* + 1/2, *z*.

2.3. Optimized Molecular Geometry
---------------------------------

From the XRD data, it is clear that the compounds **1a** and **2b** possess monoclinic, whereas, **2a** has trigonal crystal structures. The cell dimensions and other data are tabulated in [Table 1](#molecules-19-17187-t001){ref-type="table"}. Selected values of experimental and DFT calculated geometric parameters for the compounds are listed in [Table 2](#molecules-19-17187-t002){ref-type="table"}, [Table 4](#molecules-19-17187-t004){ref-type="table"}, [Table 6](#molecules-19-17187-t006){ref-type="table"} and [Table 8](#molecules-19-17187-t008){ref-type="table"}. [Figure 3](#molecules-19-17187-f003){ref-type="fig"} shows the optimized structures for **1a** and **2a**,**b**.

molecules-19-17187-t008_Table 8

###### 

Optimized calculations of various parameters for **1a** and **2a**,**b** using B3LYP/6-311G basis set.

  Parameter                      1a            2a             2b
  ------------------------------ ------------- -------------- -------------
  Heat of Formation (kcal/mol)   22.075        −100.903       −99.472
  Total Energy (kcal/mol)        −896424.216   −1244859.443   −102495.469
  Dipole (Debye)                 8.281         4.116          3.848
  HOMO energy (eV)               −10.019       −10.575        −10.813
  LUMO energy (eV)               −4.320        −2.278         −2.383
  HOMO--LUMO energy gap (eV)     5.699         8.297          8.430

![The optimized structures for **1a** and **2a**,**b**.](molecules-19-17187-g003){#molecules-19-17187-f003}

[Figure 4](#molecules-19-17187-f004){ref-type="fig"} shows the experimental and calculated (B3LYP/6-311G) IR spectrum for **1a** and **2a**,**b**. A comparison of predicted (B3LYP/6-311G) with experimental IR reveals that B3LYP/6-311G basis set gives reasonable deviations from the experimental values. The discrepancies observed between the calculated and the experimental vibrational frequencies may be attributable to the fact that the calculations have been actually performed on a single molecule in the gaseous state contrary to the experimental values recorded in the solid state in the presence of intermolecular interactions.

![Experimental and calculated IR spectra for **1a** and **2a**,**b**.](molecules-19-17187-g004){#molecules-19-17187-f004}

2.4. Experimental and Calculated IR Vibrations
----------------------------------------------

The calculated (B3LYP/6-311G) and experimental C-H, C-Cl, N=O, C=O, and C=C vibration values for all the molecules have good agreement, except for C=O for **2a**. For **2a**, the computed C=O stretching vibrations at 1894 cm^−1^ deviated substantially from the experimental result. A plausible reason for this could be the intermolecular interactions present in solid state whereas during DFT calculations the molecule is assumed to be in isolated gaseous state.

2.5. Geometric Parameters
-------------------------

The solid state X-ray structure analysis revealed disorder in the phenyl moiety for **2a** (see [Figure 2](#molecules-19-17187-f002){ref-type="fig"}). This incongruity noted between the calculated and the experimental vibrational frequencies may be due to the fact that the calculations have been actually performed on a single molecule in the gaseous state contrary to the experimental values recorded in the solid state. In DFT calculations, bond lengths and angles have been reported only for the major component of the phenyl moiety of **2a** (designated by the suffix "A"). The selected calculated and experimental geometric parameters for **1a** and **2a**,**b** have been tabulated in [Table 2](#molecules-19-17187-t002){ref-type="table"}, [Table 4](#molecules-19-17187-t004){ref-type="table"} and [Table 6](#molecules-19-17187-t006){ref-type="table"}.

2.6. Thermal Gravimetric Analysis (TGA)
---------------------------------------

The synthesized novel compounds were subjected to thermogravimetric analysis (TGA) to evaluate their thermal stability and degradation patterns ([Table 9](#molecules-19-17187-t009){ref-type="table"}) and the TGA and DTG patterns are shown in [Figure 5](#molecules-19-17187-f005){ref-type="fig"}. All samples were subjected to analysis in a nitrogen atmosphere in the temperature range from 30 °C to 800 °C with a heating ramp rate of 10 °C per min. It was observed that the different nitrostyrene derivatives displayed different thermal stabilities and degradation patterns. The pyrolysis processes of the materials are characterized by single-stage degradation, with an exception of **2a**, which displays two-stage degradation. Interestingly, it was detected that upon the incorporation of the barbituric acid ring into the styrene, the resulting molecule was slightly more thermally stable than its precursor. The weight loss pattern of all the compounds was found to be different at different intervals with **1a**,**b** displaying a weight loss of 70% and 98% respectively at 200 °C, but at the same temperature the weight loss percentage for the barbituric acid derivatives **2a**,**b** were found to be 48% and 18 % respectively. When a comparison of thermal degradation pattern between **1a** and **2a** was made it was found that **1a** undergoes single stage degradation with decomposition range of 100--190 °C (90 °C), while **2a** displays two stage degradation with decomposition taking place in the range of 105--195 °C (90 °C) and 200--275 °C (75 °C). The degradation temperature range of **1b** and **2b** was found to take place at a 162--262 °C (100 °C) and 125--230 °C (105 °C), respectively. The peak temperature of **2b** (220.02 °C) was higher than that of **1b** (199.38 °C), while the decomposition intensity of **1b** was found to be high with 2.35 wt %/°C compared to 1.99 wt %/°C **2b**. This behaviour can be attributed to the presence of barbituric acid. However, when the temperature was increased further all the compounds followed similar weight loss patterns with varying percentages of residue at the final temperature of 800 °C. From the residual weight values obtained at \~800 °C it can be concluded that there is no significant thermal stability among any of the four compounds tested, however it can be said that thermal stability of the barbituric acid derivative of the styrene molecule is slightly improved compared to that of its precursor. The weight loss percentage at different temperatures is mentioned in the table below and a comparative graphical representation of the compounds is given in [Figure 5](#molecules-19-17187-f005){ref-type="fig"}. A detailed study into the thermal behaviour of the synthesized compounds shall be carried out the thermal kinetics will be reported separately.
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###### 

Weight loss percentage at different temperatures for **1a**,**b** and **2a**,**b**.

  Temperature   Weight Loss (%)                   
  ------------- ----------------- ------- ------- -------
  100           0.33              0.63    1.42    0.44
  200           70.85             48.06   98.37   18.45
  300           98.72             91.07   98.46   84.73
  400           98.98             93.95   98.40   88.19
  500           99.11             95.67   98.29   92.93
  600           99.56             96.47   98.08   96.10
  700           99.77             97.14   97.87   98.52
  800           99.66             97.47   97.55   99.81

![TGA and DTG curves of the synthesized compounds.](molecules-19-17187-g005){#molecules-19-17187-f005}

3. Experimental Section
=======================

3.1. General
------------

All the chemicals were purchased from Aldrich (Riedstraße, Germany), Sigma-Aldrich (St. Louis, MO, USA), Fluka (Buchs, Switzerland), and used without further purification, unless otherwise stated. The structure of **1a** was confirmed by X-ray crystal structure analysis (Bruker AXS GmbH, Karlsruhe, Germany). The crystallographic data for **1a** (CCDC-992700), **2a** (CCDC-992327) and **2b** (CCDC-992701) have been submitted to the Cambridge Crystallographic Data Centre ([www.ccdc.cam.ac.uk/data_request/cif](www.ccdc.cam.ac.uk/data_request/cif)). Compound **1a** was prepared from 2,6-dicholorobenzaldehyde and nitromethane as white crystals according to the reported procedure \[[@B16-molecules-19-17187]\]. Colorless block-shaped crystals of the compound suitable for X-ray analysis were formed in isopropanol/heptane at room temperature after 3 days.

3.2. 5-(1-(2,6-Dichlorophenyl)-2-nitroethyl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (**2a**)
---------------------------------------------------------------------------------------------------

According to the reported procedure \[[@B16-molecules-19-17187]\], **2a** was prepared from 1,3-dimethylbarbituric acid (**1a**) and (*E*)-2,6-dichloro-1-(2-nitrovinyl)benzene (**1a**) as white crystals. Colorless block-shaped crystals of the compound suitable for X-ray analysis were formed in CHCl~3~/Et~2~O at room temperature after 2 days.

3.3. 5-(1-(2,4-Dichlorophenyl)-2-nitroethyl)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione (**2b**)
---------------------------------------------------------------------------------------------------

According to the reported procedure \[[@B16-molecules-19-17187]\], **2b** was prepared from 1,3-dimethylbarbituric acid and (*E*)-2,4-dichloro-1-(2-nitrovinyl)benzene (**1a**) as yellow crystals. Colorless block-shaped crystals of the compound suitable for X-ray analysis were formed in DCM/Pet. ether at room temperature after 1 day.

3.4. DFT Calculations
---------------------

The DFT calculations were performed using the GAMESS package. The input geometry of the synthesized molecules were optimized without imposing any external constraint on the potential energy surfaces generated by the B3LYP/6-311G(d,p) basis set for C, O, N and H atoms. The resulting optimized geometry was used as an input for vibrational frequencies calculations, with inclusion of polarization functions to handle the polar bonds such as N=O, C=O, *etc.*

4. Conclusions
==============

In a summary, pyrimidine derivatives **2a**,**b** were prepared starting from nitroalkenes **1a**,**b** using an eco-benign method. The structures for **1a** and **2a**,**b** have been characterized by their single crystal X-ray diffraction analysis. DFT/TGA/IR analyses were performed and discussed.
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###### 

Click here for additional data file.
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